Advertisement

Index by author

March 01, 2003; Volume 31,Issue 3

  1. Abraham, Trent L.

    1. Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans
      Minxia M. He, Trent L. Abraham, Thomas J. Lindsay, Hans C. Schaefer, Isabelle J. Pouliquen, Chris Payne, Boris Czeskis, Lisa A. Shipley, Stuart D. Oliver and Malcolm I. Mitchell
      Drug Metabolism and Disposition March 2003, 31 (3) 334-342; DOI: https://doi.org/10.1124/dmd.31.3.334

  2. Ahnoff, Martin

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

  3. Baron, Gabriel

    1. Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans
      Frédéric Imbert, Méryam Jardin, Christine Fernandez, Jean Charles Gantier, Françoise Dromer, Gabriel Baron, France Mentre, Ludy van Beijsterveldt, Eric Singlas and François Gimenez
      Drug Metabolism and Disposition March 2003, 31 (3) 319-325; DOI: https://doi.org/10.1124/dmd.31.3.319

  4. Bertelsen, Kirk M.

    1. Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
      Kirk M. Bertelsen, Karthik Venkatakrishnan, Lisa L. von Moltke, R. Scott Obach and David J. Greenblatt
      Drug Metabolism and Disposition March 2003, 31 (3) 289-293; DOI: https://doi.org/10.1124/dmd.31.3.289

  5. Bonifacio, M. J.

    1. Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
      P. N. Palma, M. J. Bonifácio, A. I. Loureiro, L. C. Wright, D. A. Learmonth and P. Soares-da-Silva
      Drug Metabolism and Disposition March 2003, 31 (3) 250-258; DOI: https://doi.org/10.1124/dmd.31.3.250

  6. Boobis, Alan R.

    1. Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Robert J. Edwards, Roger J. Price, Patricia S. Watts, Anthony B. Renwick, J. Michael Tredger, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition March 2003, 31 (3) 282-288; DOI: https://doi.org/10.1124/dmd.31.3.282

  7. Bowers, G.

    1. Oxidative Metabolism of Amprenavir in the Human Liver. Effect of the CYP3A Maturation
      J. M. Tréluyer, G. Bowers, N. Cazali, M. Sonnier, E. Rey, G. Pons and T. Cresteil
      Drug Metabolism and Disposition March 2003, 31 (3) 275-281; DOI: https://doi.org/10.1124/dmd.31.3.275

  8. Brandt, Ingvar

    1. CYP1A1 and CYP1B1 in Blood-Brain Interfaces: CYP1A1-Dependent Bioactivation of 7,12-Dimethylbenz(a)anthracene in Endothelial Cells
      Lizette Granberg, Anna Östergren, Ingvar Brandt and Eva B. Brittebo
      Drug Metabolism and Disposition March 2003, 31 (3) 259-265; DOI: https://doi.org/10.1124/dmd.31.3.259

  9. Bredberg, Ulf

    1. Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
      Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
      Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294

  10. Brittebo, Eva B.

    1. CYP1A1 and CYP1B1 in Blood-Brain Interfaces: CYP1A1-Dependent Bioactivation of 7,12-Dimethylbenz(a)anthracene in Endothelial Cells
      Lizette Granberg, Anna Östergren, Ingvar Brandt and Eva B. Brittebo
      Drug Metabolism and Disposition March 2003, 31 (3) 259-265; DOI: https://doi.org/10.1124/dmd.31.3.259
« Previous (Pages : 1 2 3 4 5 6 ... 8) Next »
Back to top

In this issue

Advertisement